Showing results (181-190 of 221) with videos related to
Sort By:
Pageof 23
BMJ Open|November 10, 2025
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, Alexandra Gilbert, Duncan Gilbert, et al.Nature|November 22, 2013
Upper Palaeolithic Siberian genome reveals dual ancestry of Native AmericansMaanasa Raghavan, Pontus Skoglund, Kelly E Graf, et al.The Lancet. Oncology|July 27, 2026
Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trialDavid Sebag-Montefiore, Richard Adams, Simon Gollins, et al.Journal of the National Cancer Institute|December 19, 2019
HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal TrialPaul R Barber, Gregory Weitsman, Katherine Lawler, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 9, 2024
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trialAlexander D Murphy, Catharine Porter, Ann White, et al.The Lancet. Oncology|August 8, 2017
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsHarpreet S Wasan, Peter Gibbs, Navesh K Sharma, et al.Eclinicalmedicine|July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialSomnath Mukherjee, Christopher N Hurt, Richard Adams, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trialAlexander D Murphy, Catharine Porter, Ann White, et al.BMC Cancer|October 25, 2024
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitorsMargherita Carucci, Andrew Clamp, Cong Zhou, et al.Journal of the National Cancer Institute|March 18, 2021
BRAF V600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD DatabaseRomain Cohen, Heshan Liu, Jack Fiskum, et al.Pageof 23